- Home
- SWX vs PCVX Comparison
SWX vs PCVX Comparison
Compare SWX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SWX | PCVX |
|---|---|---|
| Founded | 1931 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 7.0B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SWX | PCVX |
|---|---|---|
| Price | $89.11 | $54.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $87.40 | ★ $88.25 |
| AVG Volume (30 Days) | 490.5K | ★ 1.3M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.70% | N/A |
| EPS Growth | ★ 120.29 | N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $5,433,972,000.00 | N/A |
| Revenue This Year | $18.48 | N/A |
| Revenue Next Year | $2.61 | N/A |
| P/E Ratio | $46.62 | ★ N/A |
| Revenue Growth | ★ 9.56 | N/A |
| 52 Week Low | $72.43 | $29.10 |
| 52 Week High | $94.43 | $65.00 |
Technical Indicators
Market Signals| Indicator | SWX | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 62.50 |
| Support Level | $87.55 | $52.04 |
| Resistance Level | $89.58 | $56.04 |
| Average True Range (ATR) | 1.48 | 2.20 |
| MACD | 0.22 | 0.99 |
| Stochastic Oscillator | 78.85 | 99.02 |
Price Performance
Historical ComparisonAbout SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution segment. The Natural gas distribution segment encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. Its division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.